‌

AlphaThera SBIR Phase I Award,

A SBIR Phase I contract was awarded to AlphaThera for $150,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Overview Structured Data Issues Contributors

sbir.gov/node/1584201

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

AlphaThera

Government Agency

Government Branch

National Institutes of Health

Award Type

SBIR0

Contract Number (US Government)

268201800018C-0-0-00

Award Phase

Phase I0

Award Amount (USD)

150,0000

Abstract

The project goal is to develop reagents that can be used for mapping genome wide epigenetic changes during normal development and disease process in rare primary and patient cellsBecause conjugating proteins could result in inactivation of the proteinsit will be important to achieve efficient conjugation between antibodies and MNase while reserving the activities of both